Shp-2 Tyrosine Phosphatase Functions as a Negative Regulator of the Interferon-Stimulated Jak/STAT Pathway
Open accessAbstract
Shp-2 is an SH2 domain-containing protein tyrosine phosphatase. Although the mechanism remains to be defined, substantial experimental data suggest that Shp-2 is primarily a positive regulator in cell growth and development. We present evidence here that Shp-2, while acting to promote mitogenic signals, also functions as a negative effector in interferon (IFN)-induced growth-inhibitory and apoptotic pathways. Treatment of mouse fibroblast cells lacking a functional Shp-2 with IFN-alpha or IFN-gamma resulted in an augmented suppression of cell viability compared to that of wild-type cells. To dissect the molecular mechanism, we examined IFN-induced activation of signal transducers and activators of transcription (STATs) by electrophoretic mobility shift assay, using a specific DNA probe (hSIE). The amounts of STAT proteins bound to hSIE upon IFN-alpha or IFN-gamma stimulation were significantly increased in Shp-2(-/-) cells. Consistently, tyrosine phosphorylation levels of Stat1 upon IFN-gamma treatment and, to a lesser extent, upon IFN-alpha stimulation were markedly elevated in mutant cells. Furthermore, IFN-gamma induced a higher level of caspase 1 expression in Shp-2(-/-) cells than in wild-type cells. Reintroduction of wild-type Shp-2 protein reversed the hypersensitivity of Shp-2(-/-) fibroblasts to the cytotoxic effect of IFN-alpha and IFN-gamma. Excessive activation of STATs by IFNs was also diminished in mutant cells in which Shp-2 had been reintroduced. Together, these results establish that Shp-2 functions as a negative regulator of the Jak/STAT pathway. We propose that Shp-2 acts to promote cell growth and survival through two mechanisms, i.e., the stimulation of growth factor-initiated mitogenic pathways and the suppression of cytotoxic effect elicited by cytokines, such as IFNs.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Desensitization to IFNγ in Socs1-/- Ifnγ-/- macrophages at 240 min is probably a result of SHP-2 activity.
“probably a result of the activity of the phosphatase SHP-2 (36).”
From The Comparative Roles of Suppressor of Cytokine Signaling-1 and -3 in the Inhibition and Desensitization of Cytokine Signaling (2006) · cites this paper as [36]
The Discussion identifies SHP-2 as a negative regulator of IFN-induced STAT signaling, including responses to IFN-γ. But the Results study fibroblasts and measure signaling at 5–60 minutes; they do not establish that SHP-2 causes desensitization at 240 minutes in Socs1-/- Ifnγ-/- macrophages. (LLM, conf=0.87)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080 · see citing works
Zhong, Z., Wen, Z., & Darnell, J. E. (1994) · Science · doi:10.1126/science.8140422 · Cited by 2,070 · see citing works
A family of cytokine-inducible inhibitors of signalling
Starr, R., Willson, T. A., Viney, E. M., Murray, L. J. L., Rayner, J. R., Jenkins, B. J., Gonda, T. J., Alexander, W. S., Metcalf, D., Nicola, N. A., et al. (1997) · Nature · doi:10.1038/43206 · Cited by 2,066 · see citing works
Meraz, M. A., White, J. M., Sheehan, K. C. F., Bach, E. A., Rodig, S. J., Dighe, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81288-x · Cited by 1,656 · see citing works
Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease
Durbin, J. E., Hackenmiller, R., Simon, M. C., & Levy, D. E. (1996) · Cell · doi:10.1016/s0092-8674(00)81289-1 · Cited by 1,522 · see citing works
A new protein containing an SH2 domain that inhibits JAK kinases
Endo, T. A., Masuhara, M., Yokouchi, M., Suzuki, R., Sakamoto, H., Mitsui, K., Matsumoto, A., Tanimura, S., Ohtsubo, M., Misawa, H., et al. (1997) · Nature · doi:10.1038/43213 · Cited by 1,408 · see citing works
Structure and function of a new STAT-induced STAT inhibitor
Naka, T., Narazaki, M., Hirata, M., Matsumoto, T., Minamoto, S., Aono, A., Nishimoto, N., Kajita, T., Taga, T., Yoshizaki, K., et al. (1997) · Nature · doi:10.1038/43219 · Cited by 1,287 · see citing works
Crystal Structure of the Tyrosine Phosphatase SHP-2
Hof, P., Pluskey, S., Dhe‐Paganon, S., Eck, M. J., & Shoelson, S. E. (1998) · Cell · doi:10.1016/s0092-8674(00)80938-1 · Cited by 996 · see citing works
Specific Inhibition of Stat3 Signal Transduction by PIAS3
Chung, C. D., Liao, J., Liu, B., Rao, X., Jay, P., Berta, P., & Shuai, K. (1997) · Science · doi:10.1126/science.278.5344.1803 · Cited by 980 · see citing works
Jaks and Stats in signaling by the cytokine receptor superfamily.
Ihle, J., & Kerr, I. (1995) · Trends in Genetics · doi:10.1016/s0168-9525(00)89000-9 · Cited by 953 · see citing works
Cell Growth Arrest and Induction of Cyclin-Dependent Kinase Inhibitor p21WAF1/CIP1 Mediated by STAT1
Chin, Y. E., Kitagawa, M., Su, W.-C., You, Z.-H., Iwamoto, Y., & Fu, X.-Y. (1996) · Science · doi:10.1126/science.272.5262.719 · Cited by 893 · see citing works
A protein tyrosine kinase in the interferon alpha/beta signaling pathway.
Velazquez, L., Fellous, M., Stark, G., & Pellegrini, S. (1992) · Cell · doi:10.1016/0092-8674(92)90105-l · Cited by 777 · see citing works
Protein tyrosine phosphatases in signal transduction
Neel, B. G., & Tonks, N. K. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80063-4 · Cited by 757 · see citing works
Yoshimura, A., Ohkubo, T., Kiguchi, T., Jenkins, N. A., Gilbert, D. J., Copeland, N. G., Hara, T., & Miyajima, A. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07281.x · Cited by 751 · see citing works
Signaling by the cytokine receptor superfamily: JAKs and STATs
Ihle, J. N., Witthuhn, B. A., Quelle, F. W., Yamamoto, K., Thierfelder, W. E., Kreider, B. L., & Silvennoinen, O. (1994) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(94)90026-4 · Cited by 648 · see citing works
The SIF binding element confers sis/PDGF inducibility onto the c‐fos promoter.
Wagner, B. J., Hayes, T. E., Hoban, C. J., & Cochran, B. H. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07898.x · Cited by 592 · see citing works
Activation of the STAT Signaling Pathway Can Cause Expression of Caspase 1 and Apoptosis
Chin, Y. E., Kitagawa, M., Kuida, K., Flavell, R. A., & Fu, X.-Y. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5328 · Cited by 521 · see citing works
Defective TNF-α-Induced Apoptosis in STAT1-Null Cells Due to Low Constitutive Levels of Caspases
Kumar, A., Commane, M., Flickinger, T. W., Horvath, C. M., & Stark, G. R. (1997) · Science · doi:10.1126/science.278.5343.1630 · Cited by 508 · see citing works
Fu, X.-Y., Kessler, D. S., Veals, S. A., Levy, D. E., & Darnell, J. E., Jr. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.21.8555 · Cited by 490 · see citing works
Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp‐2
Saxton, T. M., Henkemeyer, M. J., Gasca, S., Shen, R., Rossi, D. J., Shalaby, F., Feng, G., & Pawson, T. J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.9.2352 · Cited by 481 · see citing works
Self-citationDeiss, L. P., Galinka, H., Berissi, H., Cohen, O., & Kimchi, A. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00760.x · Cited by 465 · see citing works
Fujioka, Y., Matozaki, T., Noguchi, T., Iwamatsu, A., Yamao, T., Takahashi, N., Tsuda, M., Takada, T., & Kasuga, M. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.12.6887 · Cited by 448 · see citing works
Interferons and other regulatory cytokines
Demaeyer, E. M., & Maeyer‐Guignard, J. D. (1988) · Medical Entomology and Zoology · Cited by 420 · see citing works
Müller, M., Laxton, C., Briscoe, J., Schindler, C., Improta, T., Darnell, J. E., Stark, G. R., & Kerr, I. M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06106.x · Cited by 411 · see citing works
Perkins, L. A., Larsen, I., & Perrimon, N. (1992) · Cell · doi:10.1016/0092-8674(92)90098-w · Cited by 402 · see citing works
Protein-tyrosine Phosphatase Shp-2 Regulates Cell Spreading, Migration, and Focal Adhesion
Yu, D.-H., Qu, C., Henegariu, O., Lu, X., & Feng, G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.33.21125 · Cited by 382 · see citing works
Self-citationNoguchi, T., Matozaki, T., Horita, K., Fujioka, Y., & Kasuga, M. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.10.6674 · Cited by 376 · see citing works
David, M., Chen, H. E., Goelz, S. E., Larner, A. C., & Neel, B. G. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.12.7050 · Cited by 342 · see citing works
Tang, T. L., Freeman, R. M., O’Reilly, A. M., Neel, B. G., & Sokol, S. Y. (1995) · Cell · doi:10.1016/0092-8674(95)90498-0 · Cited by 324 · see citing works
Interferons and other regulatory cytokines
Meager, A. (1989) · Journal of Immunological Methods · doi:10.1016/0022-1759(89)90301-3 · Cited by 313 · see citing works
Kessler, D. S., Veals, S. A., Fu, X. Y., & Levy, D. E. (1990) · Genes & Development · doi:10.1101/gad.4.10.1753 · Cited by 312 · cited 1× · see citing works
“By assembling into different complexes, activated STATs bind to specific DNA sequences and enhance transcription (4, 14, 22, 24).”
BackgroundMilarski, K. L., & Saltiel, A. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31954-3 · Cited by 305 · see citing works
Levy, D. E., Lew, D. J., Decker, T., Kessler, D. S., & Darnell, J. E., Jr. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08216.x · Cited by 212 · see citing works
Herbst, R., Carroll, P. M., Allard, J. D., Schilling, J., Raabe, T., & Simon, M. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81273-8 · Cited by 211 · see citing works
Phosphotyrosine phosphatases with SH2 domains: regulators of signal transduction
Feng, G., & Pawson, T. J. (1994) · Trends in Genetics · doi:10.1016/0168-9525(94)90149-x · Cited by 184 · see citing works
Self-citationRaabe, T., Riesgo‐Escovar, J. R., Liu, X., Bausenwein, B. S., Deák, P., Maróy, P., & Hafen, E. (1996) · Cell · doi:10.1016/s0092-8674(00)81274-x · Cited by 182 · see citing works
A Deletion Mutation in the SH2-N Domain of Shp-2 Severely Suppresses Hematopoietic Cell Development
Qu, C., Shi, Z., Shen, R., Tsai, F., Orkin, S. H., & Feng, G. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5499 · Cited by 164 · see citing works
Self-citationShi, Z., Lü, W., & Feng, G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.9.4904 · Cited by 153 · see citing works
Self-citationYin, T., Shen, R., Feng, G., & Yang, Y. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.2.1032 · Cited by 138 · see citing works
Self-citationRuff-Jamison, S., Chen, K., & Cohen, S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4215 · Cited by 137 · see citing works
Qu, C., Yu, W., Azzarelli, B., Cooper, S. H., Broxmeyer, H. E., & Feng, G. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.10.6075 · Cited by 126 · see citing works
Self-citationStructural Determinants of SHP-2 Function and Specificity in Xenopus Mesoderm Induction
O’Reilly, A. M., & Neel, B. G. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.161 · Cited by 116 · see citing works
Noguchi, T., Matozaki, T., Horita, K., et al. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.10.6674-6682.1994 · Cited by 114 · see citing works
David, M., Zhou, G., Pine, R. I., Dixon, J. E., & Larner, A. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.27.15862 · Cited by 99 · see citing works
David, M., Romero, G. G., Zhang, Z., Dixon, J. E., & Larner, A. C. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53292-0 · Cited by 96 · see citing works
Igarashi, K., David, M., Larner, A. C., & Finbloom, D. S. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.7.3984 · Cited by 90 · see citing works
You, M., & Zhao, Z. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.37.23376 · Cited by 75 · see citing works
Self-citationShp-2 has a positive regulatory role in ES cell differentiation and proliferation
Qu, C., & Feng, G. (1998) · Oncogene · doi:10.1038/sj.onc.1201920 · Cited by 75 · see citing works
Self-citationIgarashi, K., David, M., Finbloom, D. S., & Larner, A. C. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.3.1634 · Cited by 63 · see citing works
Downregulation of platelet-derived growth factor receptor-β in Shp-2 mutant fibroblast cell lines
Lu, X., Qu, C., Shi, Z., & Feng, G. (1998) · Oncogene · doi:10.1038/sj.onc.1201988 · Cited by 15 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Interferon-γ: an overview of signals, mechanisms and functions
Schroder, K., Hertzog, P. J., Ravasi, T., & Hume, D. A. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0603252 · Cited by 4,120 · see citing works
Interferon-stimulated genes: A complex web of host defenses
Schneider, W. M., Chevillotte, M. D., & Rice, C. M. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120231 · Cited by 3,067 · see citing works
STATs: transcriptional control and biological impact
Levy, D. E., & Darnell, J. E. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm909 · Cited by 3,201 · see citing works
The JAK/STAT signaling pathway: from bench to clinic
Hu, X., li, J., Fu, M., Zhao, X., & Wang, W. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00791-1 · Cited by 2,633 · see citing works
Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome
Tartaglia, M., Mehler, E. L., Goldberg, R. B., Zampino, G., Brunner, H. G., Kremer, H., van der Burgt, I., Crosby, A. H., Ion, A., Jeffery, S., et al. (2001) · Nature Genetics · doi:10.1038/ng772 · Cited by 1,736 · see citing works
Regulation of JAK–STAT signalling in the immune system
Shuai, K., & Liu, B. (2003) · Nature reviews. Immunology · doi:10.1038/nri1226 · Cited by 1,379 · see citing works
PTP1B Regulates Leptin Signal Transduction In Vivo
Zabolotny, J. M., Bence, K. K., Stricker‐Krongrad, A., Haj, F. G., Wang, Y., Minokoshi, Y., Kim, Y., Elmquist, J. K., Tartaglia, L. A., Kahn, B. B., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00148-x · Cited by 816 · see citing works
The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells
Seif, F., Khoshmirsafa, M., Aazami, H., Mohsenzadegan, M., Sedighi, G. R., & Bahar, M. (2017) · Cell Communication and Signaling · doi:10.1186/s12964-017-0177-y · Cited by 774 · see citing works
The Role of Zinc in Antiviral Immunity
Read, S. A., Obeid, S., Ahlenstiel, C., & Ahlenstiel, G. (2019) · Advances in Nutrition · doi:10.1093/advances/nmz013 · Cited by 754 · see citing works
Alspach, E., Lussier, D. M., & Schreiber, R. D. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028480 · Cited by 617 · see citing works
STAT proteins: From normal control of cellular events to tumorigenesis
Calò, V., Migliavacca, M., Bazan, V., Macaluso, M., Buscemi, M., Gebbia, N., & Russo, A. D. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10364 · Cited by 606 · see citing works
Negative Regulation of Cytokine Signaling Pathways
Yasukawa, H., Sasaki, A. T., & Yoshimura, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.143 · Cited by 596 · see citing works
Stat1-dependent and -independent pathways in IFN-γ-dependent signaling
Ramana, C. V., Gil, M. P., Schreiber, R. D., & Stark, G. R. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(01)02118-4 · Cited by 555 · see citing works
STAT proteins: novel molecular targets for cancer drug discovery
Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1204086 · Cited by 643 · see citing works
Biology and significance of the JAK/STAT signalling pathways
Kiu, H., & Nicholson, S. E. (2012) · Growth Factors · doi:10.3109/08977194.2012.660936 · Cited by 470 · see citing works
Cornel, A. M., Mimpen, I. L., & Nierkens, S. (2020) · Cancers · doi:10.3390/cancers12071760 · Cited by 471 · see citing works
Janus kinases: components of multiple signaling pathways
Rane, S. G., & Reddy, E. (2000) · Oncogene · doi:10.1038/sj.onc.1203925 · Cited by 504 · see citing works
Type I Interferon Receptors: Biochemistry and Biological Functions
de Weerd, N. A., Samarajiwa, S., & Hertzog, P. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r700006200 · Cited by 390 · see citing works
Regulation of the Jak2 Tyrosine Kinase by Its Pseudokinase Domain
Saharinen, P., Takaluoma, K., & Silvennoinen, O. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.10.3387-3395.2000 · Cited by 366 · see citing works
Divergent Roles of SHP-2 in ERK Activation by Leptin Receptors
Bjørbæk, C., Buchholz, R. M., Davis, S. M., Bates, S. H., Pierroz, D. D., Gu, H., Neel, B. G., Myers, M. G., & Flier, J. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007439200 · Cited by 364 · see citing works
Structure, function, and regulation of STAT proteins.
Lim, C. P., & Cao, X. (2006) · Molecular Biosystems · doi:10.1039/b606246f · Cited by 355 · see citing works
Complex roles of Stat1 in regulating gene expression
Ramana, C. V., Chatterjee‐Kishore, M., Nguyen, H., & Stark, G. R. (2000) · Oncogene · doi:10.1038/sj.onc.1203525 · Cited by 335 · see citing works
Ptpn11/Shp2 Acts as a Tumor Suppressor in Hepatocellular Carcinogenesis
Bard-Chapeau, E. A., Li, S., Ding, J., Zhang, S. S., Zhu, H. H., Princen, F., Fang, D. D., Han, T., Bailly-Maitre, B., Poli, V., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.03.023 · Cited by 332 · see citing works
Self-citationThe molecular regulation of Janus kinase (JAK) activation
Babon, J. J., Lucet, I. S., Murphy, J. M., Nicola, N. A., & Varghese, L. N. (2014) · Biochemical Journal · doi:10.1042/bj20140712 · Cited by 327 · see citing works
Signal transducer and activator of transcription proteins in leukemias
Beneklı, M., Baer, M. R., Baumann, H., & Wetzler, M. (2003) · Blood · doi:10.1182/blood-2002-04-1204 · Cited by 326 · see citing works
The Jak-Stat pathway in normal and perturbed hematopoiesis
Ward, A. C., Touw, I. P., & Yoshimura, A. (2000) · Blood · doi:10.1182/blood.v95.1.19.001k34_19_29 · Cited by 314 · see citing works
Kim, H. Y., Park, E. J., Joe, E.-H., & Jou, I. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.6072 · Cited by 313 · see citing works
Protein tyrosine phosphatases in the JAK/STAT pathway
Xu, D. (2008) · Frontiers in bioscience · doi:10.2741/3051 · Cited by 309 · see citing works
Interferon α/β-mediated inhibition and promotion of interferon γ: STAT1 resolves a paradox
Nguyen, K. B., Cousens, L. P., Doughty, L., Pien, G. C., Durbin, J. E., & Biron, C. A. (2000) · Nature Immunology · doi:10.1038/76940 · Cited by 303 · see citing works
Gene modulation and immunoregulatory roles of Interferonγ
Saha, B., Prasanna, S. J., Subramanian, B. C., & Nandi, D. (2009) · Cytokine · doi:10.1016/j.cyto.2009.11.021 · Cited by 300 · see citing works
NOONAN SYNDROME AND RELATED DISORDERS: Genetics and Pathogenesis
Tartaglia, M., & Gelb, B. D. (2005) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.6.080604.162305 · Cited by 355 · see citing works
STAT1 as a key modulator of cell death
Kim, H. S., & Lee, M. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.09.003 · Cited by 280 · see citing works
Li, S., Labrecque, S., Gauzzi, M. C., Cuddihy, A. R., Wong, A. H.-T., Pellegrini, S., Matlashewski, G., & Koromilas, A. E. (1999) · Oncogene · doi:10.1038/sj.onc.1202960 · Cited by 273 · see citing works
Signaling pathways activated by interferons
Platanias, L. C., & Fish, E. N. (1999) · Experimental Hematology · doi:10.1016/s0301-472x(99)00109-5 · Cited by 271 · see citing works
Franchimont, D. P., Galon, J., Gadina, M., Visconti, R., Zhou, Y.-J., Aringer, M., Frucht, D. M., Chrousos, G. P., & O’Shea, J. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.1768 · Cited by 261 · see citing works
Yamamoto, T., Sekine, Y., Kashima, K., Kubota, A., Sato, N., Aoki, N., & Matsuda, T. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02291-x · Cited by 250 · see citing works
An, H., Zhao, W., Hou, J., Zhang, Y., Xie, Y., Zheng, Y., Xu, H., Qian, C., Zhou, J., Yu, Y., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.10.014 · Cited by 246 · see citing works
Self-citationJAKs, STATs and Src kinases in hematopoiesis
Rane, S. G., & Reddy, E. P. (2002) · Oncogene · doi:10.1038/sj.onc.1205398 · Cited by 241 · see citing works
González, R. R., Cherfils, S., Escobar, M., Yoo, J. H., Cariño, C., Styer, A. K., Sullivan, B. T., Sakamoto, H., Olawaiye, A., Serikawa, T., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601991200 · Cited by 242 · see citing works
Shp-2 Tyrosine Phosphatase: Signaling One Cell or Many
Feng, G.-S. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4668 · Cited by 285 · see citing works
Self-citationSensitization of IFN-γ Jak-STAT signaling during macrophage activation
Hu, X., Herrero, C., Li, W.-P., Antoniv, T. T., Falck-Pedersen, E., Koch, A. E., Woods, J. M., Haines, G. K., & Ivashkiv, L. B. (2002) · Nature Immunology · doi:10.1038/ni828 · Cited by 233 · see citing works
Chong, Z. Z., & Maiese, K. (2007) · PubMed · doi:10.14670/hh-22.1251 · Cited by 228 · see citing works
Recent Advances of SHP2 Inhibitors in Cancer Therapy: Current Development and Clinical Application
Yuan, X., Bu, H., Zhou, J., Yang, C., & Zhang, H. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00249 · Cited by 224 · see citing works
West Nile Virus Inhibits the Signal Transduction Pathway of Alpha Interferon
Guo, J., Hayashi, J., & Seeger, C. (2005) · Journal of Virology · doi:10.1128/jvi.79.3.1343-1350.2005 · Cited by 219 · see citing works
Differential Regulation of Type I and Type III Interferon Signaling
Stanifer, M. L., Pervolaraki, K., & Boulant, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061445 · Cited by 214 · see citing works
Li, F., Fernández, P., Rajendran, P., Hui, K. M., & Sethi, G. (2010) · Cancer Letters · doi:10.1016/j.canlet.2009.12.003 · Cited by 189 · see citing works
Dynamic control of type I IFN signalling by an integrated network of negative regulators
Porritt, R. A., & Hertzog, P. J. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.002 · Cited by 198 · see citing works
The untold story of IFN-γ in cancer biology
Kursunel, M. A., & Esendagli, G. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.07.005 · Cited by 192 · see citing works
Gavrieli, M., Watanabe, N., Loftin, S. K., Murphy, T. L., & MURPHY, K. M. M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.070 · Cited by 190 · see citing works
Requirement of Histone Deacetylase Activity for Signaling by STAT1
Klampfer, L., Huang, J., Swaby, L.-A., & Augenlicht, L. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401359200 · Cited by 187 · see citing works
Control mechanism of JAK/STAT signal transduction pathway
Yamada, S., Shiono, S., Joo, A., & Yoshimura, A. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03842-5 · Cited by 184 · see citing works
Li, F., Rajendran, P., & Sethi, G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00874.x · Cited by 176 · see citing works
Klampfer, L. (2006) · Current Cancer Drug Targets · doi:10.2174/156800906776056491 · Cited by 171 · see citing works
Wu, T., Hong, Y. K., Wang, X., Ling, M. Y., Dragoi, A. M., Chung, A. S., Campbell, A. G., Han, Z.-Y., Feng, G., & Chin, Y. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207536200 · Cited by 170 · see citing works
Self-citationThe SHP-2 tyrosine phosphatase: Signaling mechanisms and biological functions
Qu, C. (2000) · Cell Research · doi:10.1038/sj.cr.7290055 · Cited by 167 · see citing works
Zagorulya, M., Yim, L., Morgan, D. M., Edwards, A. W., Torres-Mejia, E., Momin, N., McCreery, C. V., Zamora, I., Horton, B. L., Fox, J. G., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.01.010 · Cited by 157 · see citing works
Targeting Protein Tyrosine Phosphatases for Anticancer Drug Discovery
Scott, L. M., Lawrence, H. R., Sebti, S. M., Lawrence, N. J., & Wu, J. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791209027 · Cited by 160 · see citing works
Ivashkiv, L. B., & Hu, X. (2004) · Arthritis Research · doi:10.1186/ar1197 · Cited by 152 · see citing works
Suppressors of Cytokine Signaling (SOCS): Inhibitors of the JAK/STAT Pathway
Cooney, R. N. (2002) · Shock · doi:10.1097/00024382-200202000-00001 · Cited by 152 · see citing works
Molecular Pathways: Targeting Protein Tyrosine Phosphatases in Cancer
Bollu, L. R., Mazumdar, A., Savage, M. I., & Brown, P. H. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0934 · Cited by 168 · see citing works
Patil, S. P., Newman, D. K., & Newman, P. J. (2001) · Blood · doi:10.1182/blood.v97.6.1727 · Cited by 144 · see citing works
Germ-line and somatic PTPN11 mutations in human disease
Tartaglia, M., & Gelb, B. D. (2005) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2005.03.001 · Cited by 141 · see citing works
Saydmohammed, M., Joseph, D., & Syed, V. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22558 · Cited by 140 · see citing works
Mechanism of protein tyrosine phosphatase 1B-mediated inhibition of leptin signalling
Lund, I. K., Hansen, J. A., Andersen, H. S., Møller, N. P. H., & Billestrup, N. (2005) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01694 · Cited by 136 · see citing works
Tangye, S. G., Phillips, J. H., & Lanier, L. L. (2000) · Seminars in Immunology · doi:10.1006/smim.2000.0217 · Cited by 136 · see citing works
Stofega, M. R., Herrington, J. B., Billestrup, N., & Carter‐Su, C. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.9.0513 · Cited by 134 · see citing works
Lee, J. H., Kim, C., Kim, S., Sethi, G., & Ahn, K. S. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.02.024 · Cited by 135 · see citing works
The negative regulation of Toll‐like receptor and associated pathways
Lang, T., & Mansell, A. S. (2007) · Immunology and Cell Biology · doi:10.1038/sj.icb.7100094 · Cited by 133 · see citing works
You, M., Flick, L. M., Yu, D., & Feng, G. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.1.101 · Cited by 133 · see citing works
Self-citationIvo, P. T. (2006) · Frontiers in bioscience · doi:10.2741/2103 · Cited by 130 · see citing works
Identification of Shp-2 as a Stat5A Phosphatase
Chen, Y., Wen, R., Yang, S., Schuman, J., Zhang, E. E., Yi, T., Feng, G., & Wang, D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210572200 · Cited by 124 · see citing works
Self-citationWormald, S., Zhang, J.-G., Krebs, D. L., Mielke, L. A., Silver, J., Alexander, W. S., Speed, T. P., Nicola, N. A., & Hilton, D. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509595200 · Cited by 123 · see citing works
Mediating ERK1/2 signaling rescues congenital heart defects in a mouse model of Noonan syndrome
Nakamura, T., Colbert, M. C., Krenz, M., Molkentin, J. D., Hahn, H. S., Dorn, G. W., & Robbins, J. M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30756 · Cited by 120 · see citing works
Gamma interferon: a central mediator in atherosclerosis
León, M. L. A., & Zuckerman, S. H. (2005) · Inflammation Research · doi:10.1007/s00011-005-1377-2 · Cited by 120 · see citing works
Miyakawa, Y., Rojnuckarin, P., Habib, T., & Kaushansky, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m002633200 · Cited by 120 · see citing works
Role of the SHP-2 tyrosine phosphatase in cytokine-induced signaling and cellular response
Qu, C. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00322-1 · Cited by 120 · see citing works
SHP-2 and myeloid malignancies
Tartaglia, M., Niemeyer, C. M., Shannon, K., & Loh, M. L. (2003) · Current Opinion in Hematology · doi:10.1097/00062752-200401000-00007 · Cited by 118 · see citing works
Negative regulation of type I IFN signaling
Arimoto, K.-I., Miyauchi, S., Stoner, S. A., Fan, J.-B., & Zhang, D.-E. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.2mir0817-342r · Cited by 117 · see citing works
A comprehensive review of SHP2 and its role in cancer
Asmamaw, M. D., Shi, X.-J., Zhang, L.-R., & Liu, H.-M. (2022) · Cellular Oncology · doi:10.1007/s13402-022-00698-1 · Cited by 119 · see citing works
The multi‐faceted cross‐talk between the insulin and angiotensin II signaling systems
Velloso, L. A., Folli, F. B., Perego, L., & Saad, M. J. A. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.611 · Cited by 115 · see citing works
Hepatitis delta virus inhibits alpha interferon signaling #
Pugnale, P., Pazienza, V., Guilloux, K., & Negro, F. (2008) · Hepatology · doi:10.1002/hep.22654 · Cited by 111 · see citing works
Wang, C.-Z., Su, H.-W., Hsu, Y.-C., Shen, M., & Tang, M. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-11-1068 · Cited by 112 · see citing works
Escape from IFN-γ-dependent immunosurveillance in tumorigenesis
Lin, C., Lin, C.-M., Lee, K.-Y., Chen, K.-Y., Feng, P., Chen, C., Chuang, H., Chen, C.-L., Wang, Y., Tseng, P., et al. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-017-0317-0 · Cited by 108 · see citing works
Signal Transduction in Natural Killer Cells
Macfarlane, A. W., & Campbell, K. S. (2005) · Current topics in microbiology and immunology · doi:10.1007/3-540-27743-9_2 · Cited by 105 · see citing works
SHP-2 Positively Regulates Myogenesis by Coupling to the Rho GTPase Signaling Pathway
Kontaridis, M. I., Eminaga, S., Fornaro, M., Zito, C. I., Sordella, R., Settleman, J. E., & Bennett, A. M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.12.5340-5352.2004 · Cited by 104 · see citing works
Cell Type-Specific Signaling in Response to Interferon-γ
van Boxel-Dezaire, A. H. H., & Stark, G. R. (2007) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-71329-6_7 · Cited by 98 · see citing works
STAT5 Signaling in Sexually Dimorphic Gene Expression and Growth Patterns
Davey, H. W., Wilkins, R. J., & Waxman, D. J. (1999) · The American Journal of Human Genetics · doi:10.1086/302599 · Cited by 98 · see citing works
Autophagy Facilitates IFN-γ-induced Jak2-STAT1 Activation and Cellular Inflammation
Chang, Y.-P., Tsai, C., Huang, W., Wang, C., Chen, C., Lin, Y.-S., Kai, J.-I., Hsieh, C.-Y., Cheng, Y., Choi, P.-C., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.133355 · Cited by 93 · see citing works
Kontaridis, M. I., Yang, W., Bence, K. K., Cullen, D., Wang, B., Bodyak, N. D., Ke, Q., Hinek, A., Kang, P. M., Liao, R., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.728865 · Cited by 93 · see citing works
Feedback regulation of RTK signaling in development
Neben, C. L., Lo, M., Jura, N., & Klein, O. D. (2017) · Developmental Biology · doi:10.1016/j.ydbio.2017.10.017 · Cited by 83 · see citing works
New pharmacokinetic and pharmacodynamic tools for interferon-alpha (IFN-?) treatment of human cancer
Tagliaferri, P., Caraglia, M., Budillon, A., Marra, M., Vitale, G., Viscomi, C., Masciari, S., Tassone, P., Abbruzzese, A., & Venuta, S. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0549-1 · Cited by 85 · see citing works
The major vault protein is responsive to and interferes with interferon-γ-mediated STAT1 signals
Steiner, E., Holzmann, K., Pirker, C., Elbling, L., Micksche, M., Sutterlüty, H., & Berger, W. (2006) · Journal of Cell Science · doi:10.1242/jcs.02773 · Cited by 84 · see citing works
Mann, B. A., Huang, J. H., Li, P., Chang, H., Slee, R. B., O’Sullivan, A., Anita, M., Yeh, N., Klemsz, M. J., Brutkiewicz, R. R., et al. (2008) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2007.0113 · Cited by 83 · see citing works
Tsai, C., Kai, J.-I., Huang, W., Wang, C., Wang, Y., Chen, C., Fang, Y.-T., Lin, Y.-S., Anderson, R., Chen, S., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804033 · Cited by 81 · see citing works
Troegeler, A., Mercier, I., Cougoule, C., Pietretti, D., Colom, A., Duval, C., Manh, T. V., Capilla, F., Poincloux, R., Pingris, K., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613254114 · Cited by 82 · see citing works
The long non-coding RNA LUCAT1 is a negative feedback regulator of interferon responses in humans
Agarwal, S., Vierbuchen, T., Ghosh, S., Chan, J., Jiang, Z., Kandasamy, R. K., Ricci, E. P., & Fitzgerald, K. A. (2020) · Nature Communications · doi:10.1038/s41467-020-20165-5 · Cited by 79 · see citing works
Tanuma, N., Nakamura, K., Shima, H., & Kikuchi, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003661200 · Cited by 79 · see citing works
Qing, Y., Costa-Pereira, A., Watling, D., & Stark, G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409863200 · Cited by 95 · see citing works
Shp2-mediated molecular signaling in control of embryonic stem cell self-renewal and differentiation
Feng, G. (2007) · Cell Research · doi:10.1038/sj.cr.7310140 · Cited by 77 · see citing works
Self-citationSHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms
Wang, Y., Mohseni, M., Grauel, A., Diez, J. E., Guan, W., Liang, S., Choi, J. E., Pu, M., Chen, D., Laszewski, T., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-80999-x · Cited by 73 · see citing works
- Authors
- You, M., Yu, D.-H., & Feng, G.-S.
- Affiliations
- Indiana University Indianapolis (US)
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1999-03
- Volume
- 19
- Issue
- 3
- Pages
- 2416-2424
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC84034
- OpenAlex
- W2114990619
- Cited by
- 364
- References
- 50
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 8 · 2023: 5 · 2022: 7 · 2021: 12 · 2020: 11 · 2019: 10 · 2018: 8 · 2017: 13 · 2016: 13 · 2015: 12 · 2014: 11 · 2013: 18 · 2012: 14
- FWCI
- 7.48
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health
- National Institute of General Medical Sciences (R29GM53660, R29GM053660)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- SHP2, protein tyrosine phosphatase, JAK/STAT signaling, interferon-alpha, interferon-gamma, STAT1 tyrosine phosphorylation, caspase-1, apoptosis, cell growth inhibition, negative regulation, SH2 domain, fibroblasts
- MeSH terms
- Interferon gamma Receptor, Animals, Cell Line, DNA-Binding Proteins, Enzyme Induction, Fibroblasts, Humans, Interferon-gamma, Membrane Proteins, Phenotype, Phosphorylation, Protein-Tyrosine Kinases, Signal Transduction, Trans-Activators, Mutagenesis, Interferon-alpha, Protein Tyrosine Phosphatases, Receptors, Interferon, Caspase 1, Intracellular Signaling Peptides and Proteins, STAT1 Transcription Factor, STAT2 Transcription Factor, Mice, Janus Kinase 1, Receptor, Interferon alpha-beta, Protein Tyrosine Phosphatase, Non-Receptor Type 6, Protein Tyrosine Phosphatase, Non-Receptor Type 11, SH2 Domain-Containing Protein Tyrosine Phosphatases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review